GlassScriptPhysician profile
Robert F Noonan
NPI 1902867070
$3,804.53
in general payments reported to CMS, 2019-2025
38 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $764 · 2021: $436 · 2022: $603 · 2023: $578 · 2024: $598 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,387.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $705.81 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $402.93 | 2019-2021 | |
| Novo Nordisk INC | $398.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $234.85 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $218.02 | 2019-2024 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $216.81 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $197.18 | 2020-2024 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.33 | 2019-2024 | Jardiance |
| Allergan, INC. | $179.45 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $126.39 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $119.99 | 2022-2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $99.78 | 2022 | |
| Boston Scientific Corporation | $77.96 | 2021-2023 | Watchman Access System, Watchman |
| Abbott Laboratories | $68.52 | 2021-2024 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $64.64 | 2019-2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Noonan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.